Has the French Specialty Chemicals Industry valuation changed over the past few years?

Investors are optimistic on the French Specialty Chemicals industry, and appear confident in long term growth rates. The industry is trading at a PE ratio of 56.6x which is higher than its 3-year average PE of 26.2x. The industry is trading close to its 3-year average PS ratio of 0.69x.

How does French Specialty Chemicals compare with similar industries?

There are no additional sub-industries under this industry.

French (CAC) Specialty Chemicals Industry Analysis

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Sat, 08 Aug 2026	€6.6b	€10.2b	€117.2m	20.8x	56.7x	0.7x
Mon, 06 Jul 2026	€6.3b	€10.1b	€115.7m	20.1x	54.5x	0.6x
Wed, 03 Jun 2026	€6.7b	€10.1b	€115.7m	23.5x	57.7x	0.7x
Fri, 01 May 2026	€6.6b	€10.3b	€140.3m	18x	46.8x	0.6x
Sun, 29 Mar 2026	€6.2b	€10.3b	€134.2m	15.8x	46.2x	0.6x
Tue, 24 Feb 2026	€6.4b	€10.5b	€217.5m	26.6x	29.6x	0.6x
Thu, 22 Jan 2026	€5.7b	€10.5b	€217.5m	23.9x	26.4x	0.5x
Sat, 20 Dec 2025	€5.8b	€10.5b	€217.5m	24.2x	26.7x	0.6x
Mon, 17 Nov 2025	€5.9b	€10.5b	€217.5m	24.3x	26.9x	0.6x
Wed, 15 Oct 2025	€5.5b	€10.7b	€282.1m	17.9x	19.5x	0.5x
Fri, 12 Sep 2025	€6.2b	€10.7b	€255.6m	18.9x	24.2x	0.6x
Sun, 10 Aug 2025	€6.5b	€10.7b	€255.6m	20.3x	25.5x	0.6x
Tue, 08 Jul 2025	€6.4b	€10.8b	€372.6m	17.6x	17.1x	0.6x
Thu, 05 Jun 2025	€6.5b	€10.8b	€372.6m	19x	17.5x	0.6x
Sat, 03 May 2025	€6.8b	€10.7b	€395.6m	16.8x	17.2x	0.6x
Mon, 31 Mar 2025	€7.2b	€10.7b	€397.5m	18.7x	18.2x	0.7x
Wed, 26 Feb 2025	€8.1b	€10.6b	€404.2m	20.1x	19.9x	0.8x
Fri, 24 Jan 2025	€7.6b	€10.6b	€404.2m	20.2x	18.7x	0.7x
Sun, 22 Dec 2024	€7.4b	€10.9b	€376.1m	20.5x	19.6x	0.7x
Tue, 19 Nov 2024	€7.9b	€10.9b	€376.1m	21x	21.1x	0.7x
Thu, 17 Oct 2024	€8.5b	€10.9b	€393.3m	20.6x	21.5x	0.8x
Sat, 14 Sep 2024	€8.3b	€11.0b	€334.8m	26.5x	24.7x	0.8x
Mon, 12 Aug 2024	€7.9b	€11.0b	€334.8m	23.6x	23.7x	0.7x
Wed, 10 Jul 2024	€8.1b	€10.9b	€341.8m	22.8x	23.6x	0.7x
Fri, 07 Jun 2024	€8.8b	€10.9b	€345.2m	24.3x	25.6x	0.8x
Sun, 05 May 2024	€9.4b	€11.1b	€384.8m	24.3x	24.4x	0.8x
Tue, 02 Apr 2024	€9.2b	€11.1b	€400.6m	18.2x	23x	0.8x
Thu, 29 Feb 2024	€9.3b	€11.4b	€404.2m	18.6x	23x	0.8x
Sat, 27 Jan 2024	€9.7b	€11.4b	€404.2m	19.5x	23.9x	0.8x
Mon, 25 Dec 2023	€9.6b	€11.4b	€404.2m	19.4x	23.8x	0.8x
Wed, 22 Nov 2023	€8.7b	€11.4b	€404.2m	17.4x	21.6x	0.8x
Fri, 20 Oct 2023	€8.3b	€12.0b	€513.6m	12.6x	16.1x	0.7x
Sun, 17 Sep 2023	€9.0b	€12.1b	€531.2m	13.8x	17x	0.7x
Tue, 15 Aug 2023	€9.4b	€12.1b	€531.4m	14.4x	17.7x	0.8x


FR Market	2.37%
Materials	1.27%
Chemicals	1.13%
Specialty Chemicals	3.46%
Commodity Chemicals	3.21%
Industrial Gases	0.97%
Fertilizers and Agricultural Chemicals	0%	0
Diversified Chemicals	-0.79%

Company	Last Price	7D	1Y	Valuation
AKE Arkema	€61.45	4.3% +€192.8m	-1.4%	PE251.1x
RBT Robertet	€810.00	1.8% +€31.1m	-1.9%	PE17.4x
ALGAE Fermentalg	€0.48	4.0% +€1.8m	-5.6%	PS3.4x
ALMIB Amoéba	€0.73	2.0% +€964.4k	-13.6%	PS72.3x

Announcement • Jul 02

Amoéba Receives Marketing Authorization For Biofungicide AXPERA In France

Amoéba has obtained marketing authorization for its biofungicide AXPERA in France. This first authorisation, granted by ANSES following the evaluation conducted by France in its capacity as rapporteur Member State for European Union, now allows the other concerned Member States concerned to proceed with and finalise their national authorisation procedures in the coming weeks and months, according to each country’s specific timelines. This authorization marks the launch of the commercialization phase for AXPERA in partnership with Koppert, initially in France and then in the other European countries covered by the agreement once approvals have been granted by the relevant national authorities. AXPERA is approved by ANSES as a fungicide that acts by inhibiting the germination of fungal spores. The product is now approved for the following uses: Grapes (wine and table grapes) for Downy mildew and Powdery mildew in open field; Cucurbits for Downy mildew in open field and Powdery mildew in open field and protected conditions; Tomatoes for Late blight in open field and protected conditions and Powdery mildew in protected conditions; Eggplant for Late blight in open field and protected conditions and Powdery mildew in protected conditions; Basil for Downy mildew in open field; Lettuce (including baby leafs) for Downy mildew in open field; Artichokes for Downy mildew in open field. The product is intended for preventive use; it can be used alone, as part of a treatment program, or in combination with other fungicides approved for use against the specific disease. AXPERA is approved as a low-risk product and can be used in both conventional and organic agriculture in accordance with applicable regulations. The authorized application conditions of use contribute to the product’s appeal to farmers by combining protection, effectiveness, and ease of use. In particular, they result in the shortest re-entry period and pre-harvest interval, as well as the shortest safety distances granted by ANSES for a plant protection product. The active ingredient of AXPERA, the “Lysate of Willaertia magna C2c Maky,” is included on the list of active ingredients exempt from maximum residue limits (MRLs), offering a significant regulatory advantage: it facilitates the marketing of crops by eliminating the need for testing on treated foodstuffs. The AXPERA product is intended to be included on the French list of biocontrol products. This inclusion would offer several advantages, in particular: Meeting growing environmental and health expectations; Facilitating procedures, certifications, and specifications that promote products respectful of the environment and consumers, such as the “High Environmental Value” (Haute Valeur Environnementale) or “Zero Pesticide Residue” labels; Enhancing the product’s social acceptability and value among farmers, distributors, and industry sectors; Integrating the product into the French National Biocontrol Strategy; Getting authorization for commercial advertising. Now that the product has been approved in France - which acted as the zonal rapporteur Member State for the product’s evaluation - the other concerned Member States will be able to finalize their national approval procedures: Applications for open-field use have already been submitted in Portugal, Spain, Italy, and Greece. Applications for protected uses have already been submitted in Portugal, Spain, Italy, Greece, Belgium, Poland, and Germany. These protected uses will also be the subject of a mutual recognition application in 12 additional Member States, with a view to market access starting in 2027. This first marketing authorization in Europe, valid for a renewable 15-year period, thus serves as a major lever, facilitating future geographic expansions as well as the extension of uses, both in terms of crops and targeted diseases.

French (CAC) Specialty Chemicals Industry Analysis

Industry Valuation and Performance

Industry Comparison

Top Stock Gainers and Losers

Latest News

New minor risk - Share price stability

Now 20% undervalued

Second quarter 2026 earnings released: EPS: €0.33 (vs €0.31 in 2Q 2025)

Consensus EPS estimates fall by 19%

Baikowski SA to Report First Half, 2026 Results on Sep 28, 2026

Price target decreased by 8.6% to €0.64

Amoéba Receives Marketing Authorization For Biofungicide AXPERA In France